Found "Early HTA": 383 results
Sort by
Z - A

Evaluation on health and economic impacts of unsafe food in Thailand

17-2-021-2559(2)economic impact,health impact,health technology,HITA,HITAP,HTA,Unsafe food,การประเมินเทคโนโลยีและนโยบายด้านสุขภาพ,ประเมินผลกระทบ,อาหารไม่ปลอดภัย

Evaluating the Value of a Real-world HTA agency (EVORA)

In 2018-19, HITAP collaborated with the University of Strathclyde to conduct a study on assessing the value of HTA agencies as part of the Evaluating the Value of a Real-world HTA agency (EVORA) project. The three outputs from this study are an Excel-based simulation model, a logic model on the impact of HTA agencies and a review of literature. The

Evaluating the Value of a Real-World HTA Agency

As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about

Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges

Generic reference cases for economic evaluation (EE) of “cure-based” health technologies may not fit into the new healthcare paradigm of precision medicine (PM). Current EE approaches were challenged by the complex evolving decision space of PM, lack of clinical evidence due to small patient cluster

Evaluating HITAP: 2 years on

\"First Step”, a program evaluation report, assessing HITAP’s two-year efforts and providing recommendations for further development of HITAP. This program evaluation was conducted by four external evaluators including Prof. John Cairns, Dr. Kalipso Chalkidou, Prof. Paibul Suriyawongpaisal, and Dr. Jirawat Panpiemras. Moreover, Prof. Mark Sculp

Establishment of the Medical Technology Assessment Board (MTAB): Initiating Health Technology Assessment (HTA) in India

Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in colla

EQUITY AS A CORNERSTONE OF A STRONG HEALTH SYSTEM: LESSONS FROM THE COVID-19 PANDEMIC

As we approach the end of an unprecedented year, the approval of select COVID-19 vaccines by stringent regulatory authorities and programmatic roll-out has been cause for optimism. However, it is imperative to assure equitable access to those in need in all regions of the world as a core component o

Empowering Ghana’s Path to Sustainable Healthcare: HITAP’s HTA Capacity Building Workshop in Ghana

On 2nd – 6th October 2023, HITAP hosted a topic selection workshop and communication training for relevant HTA stakeholders in Ghana, with the support of the Access and Delivery Partnership (ADP). This workshop was held with the aims to increase awareness of health technology ass

Economic Evaluation of Rotavirus Vaccine in Bhutan

Bhutan is a rapidly growing economy that is transitioning from international donor support. As such, the country is looking for ways to ensure that they continue to provide the adequate services and support for their population in a rational and sustainable manner. Bhutan has begun using health tech

Economic Evaluation of Evusheld® for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand

The introduction of Coronavirus disease 2019 (COVID-19) vaccines urged all Thais to seek prevention of serious illness and death from COVID-19. However, immunocompromised individuals might not be able to achieve an efficient immune response from these vaccines. This study aimed to evaluate the cost-
10 / Page